Navigation Links
Research breakthrough paves the way for understanding serious diseases

A few years ago researchers described a Turkish family whose family members moved around on all fours. It turned out that they lacked the sense of equilibrium. This was caused by the rare neurological disease CAMRQ, which is the result of a mutation in the lipid pump in the cells. On the other hand, it was not known why the genetic error had such serious consequences.

The discovery provided inspiration for a Danish study of the mechanism for the vital lipid pump function, the so-called flippase, which transports lipids in the membrane that surrounds every single cell in the body. Researchers from Aarhus University have now presented a hypothesis that can explain how the flippase functions - and they have thus found the answer to a basic research question that has preoccupied researchers for years. The study has just been published in the recognised scientific journal PNAS.

Fundamental question for researchers around the world

14 different types of flippases are found in the cells. In collaboration with colleagues from Switzerland and Canada, the Danish researchers have put forward a model for how the transfer of lipid molecules takes place between the two layers in the cell membrane. The researchers created the model by mimicking the mutations from the Turkish family in the laboratory on one of the flippases - the so-called ATP8A2 - and then using computer simulations to study the structural changes of the flippase.

"With the model we have found a possible answer to the question known as 'the giant substrate problem.' It has not previously been possible to explain how a relatively small protein could transport large lipid molecules in the membrane. This fundamental question has occupied researchers around the world since the existence and size of the flippase protein became known. With the new knowledge we can understand how the mutation interferes with the lipid transport mechanism and thus, in this way, triggers disease," says postdoc Anna Lindelv Vestergaard, who is one of the researchers behind the project.

Research based on Danish Nobel Prize research

The study is based on the research tradition that Nobel Prize winner Jens Christian Skou laid the groundwork for when he became the first person to discover a pump function in the cells in the 1950s, the so-called sodium potassium pump.

The flippase and the sodium potassium pump belong to a group of a total of 36 different pump proteins that are found in the cell membranes in the body's cells. The pumps are vital and genetic defects in flippases contribute - in addition to the Turkish family's illness - to the deadly Byler's disease of the liver, involuntary childlessness and neurological diseases such as e.g. Alzheimer's disease.

"14 out of the 36 pumps in the cells are flippases. For that reason alone there is every reason to believe that they play an important role. Genetic errors in the flippases are probably the cause of many more diseases than we currently recognise. The basic scientific understanding is the first step. In the long term it can lead to us becoming better to diagnose and treat diseases that are caused by errors in a flippase," says postdoc Anna Lindelv Vestergaard, before continuing:

"The new knowledge can also be used for the development of new drugs as the flippases can also transport lipid-soluble medicines. Once we know how the medicine can get into the cell, it can be designed so that the treatment is more carefully targeted and effective."

Important step towards greater knowledge

The flippases ensure that there is asymmetry between the two lipid layers in the cell membrane, so that the membranes bend, which is necessary so that the cells can divide or fuse. This also means that the flippases are of significance during e.g. embryo development, fertilisation and the excretion of hormones from the cells into the blood.

"We surmise that the basic mechanism which we have discovered is universal for all flippases in humans and animals. So this is the first step towards far greater knowledge than we have today," says Professor Jens Peter Andersen, who has headed the study in collaboration with Anna Lindelv Vestergaard.


Contact: Jens Peter Andersen
Aarhus University

Related biology news :

1. NHAES researchers receive $482,500 grant to study nitrogen loss in soils
2. Researchers test whether Red Queen hypothesis makes species resilient
3. Compound reverses symptoms of Alzheimers disease in mice, SLU research shows
4. Nine young scientists awarded by the Genetics Society of America for fruit fly research
5. NIH researchers discover key factor in early auditory system development
6. DFG establishes 13 new research training groups
7. New research shows humans have more impact on tropical nitrogen levels
8. Scripps Research Institute chemists discover structure of cancer drug candidate
9. Google, YouTube, iPhones, Affordable Care Act featured in new research for role in hypertension
10. Eskitis links with European life science researchers
11. $31 million gift will fund early stage UW research by high-tech entrepreneurs
Post Your Comments:
Related Image:
Research breakthrough paves the way for understanding serious diseases
(Date:6/22/2016)... LOS ANGELES , June 22, 2016 ... of identity management and verification solutions, has ... cutting edge software solutions for Visitor Management, ... ® provides products that add functional ... The partnership provides corporations and venues with ...
(Date:6/16/2016)... , June 16, 2016 ... size is expected to reach USD 1.83 billion ... Grand View Research, Inc. Technological proliferation and increasing ... applications are expected to drive the market growth. ... , The development of advanced multimodal ...
(Date:6/7/2016)... , June 7, 2016  Syngrafii Inc. and ... business relationship that includes integrating Syngrafii,s patented LongPen™ ... project. This collaboration will result in greater convenience ... credit union, while maintaining existing document workflow and ... ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... , June 27, 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ... advised by its major shareholders, Clean Technology Fund I, ... United States based venture capital funds which ... Biorem (on a fully diluted, as converted basis), that ... of their entire equity holdings in Biorem to TUS ...
(Date:6/27/2016)... ... June 27, 2016 , ... Parallel 6 , the leading ... the Clinical Reach Virtual Patient Encounter CONSULT module which enables both audio ... and clinical trial team. , Using the CONSULT module, patients and physicians can schedule ...
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... , June 24, 2016 Epic Sciences ... detects cancers susceptible to PARP inhibitors by targeting ... cells (CTCs). The new test has already been ... in multiple cancer types. Over 230 ... damage response pathways, including PARP, ATM, ATR, DNA-PK ...
Breaking Biology Technology: